Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Which Is More Effective in the Treatment of Postherpetic Neuralgia: Erector Spinae Plane Block or Transcutaneous Radiofrequency?

NCT07400640 is registered in ClinicalTrials.gov with Diskapi Teaching and Research Hospital as lead sponsor.

NCT NCT07400640
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07400640 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Which Is More Effective in the Treatment of Postherpetic Neuralgia: Erector Spinae Plane Block or Transcutaneous Radiofrequency?
Lead sponsor
Diskapi Teaching and Research Hospital
Phase
Observational
Overall status
Recruiting
Start date
June 1, 2025
Completion date
October 1, 2026
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

herpes zoster, neuropathic pain, postherpetic neuralgia